Epkinly Disease Interactions
There are 2 disease interactions with Epkinly (epcoritamab).
Epcoritamab (applies to Epkinly) active infection
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Infection - Bacterial/Fungal/Protozoal/Viral
Epcoritamab can cause serious and fatal infections. Patients should be evaluated for active infection prior to epcoritamab treatment and administration should be avoided if infection is detected. Consider initiating prophylaxis against herpes virus and pneumocystis jiroveci fungus prior to starting treatment to prevent herpes zoster reactivation and pneumocystis jiroveci pneumonia infection.
Epcoritamab (applies to Epkinly) impaired cognition/consciousness
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Altered Consciousness
Epcoritamab can cause serious adverse reactions that may lead to impaired cognition or consciousness. Patients at increased risk should be evaluated and advised to refrain from operating potentially dangerous machinery until resolution.
Switch to professional interaction data
Epkinly drug interactions
There are 258 drug interactions with Epkinly (epcoritamab).
More about Epkinly (epcoritamab)
- Epkinly consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bispecific T-cell engagers (BiTE)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Truxima
Truxima is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid ...
Monjuvi
Monjuvi (tafasitamab-cxix) is used for the treatment of relapsed or refractory diffuse large B-cell ...
Breyanzi
Breyanzi is a CAR T cell therapy for large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle ...
Kymriah
Kymriah is used to treat acute lymphoblastic leukemia (ALL) that is relapsing or refractory in ...
Polivy
Polivy (polatuzumab vedotin-piiq) is a targeted treatment that may be used to treat diffuse large ...
Yescarta
Yescarta is used to treat large B-cell lymphoma and follicular lymphoma, two types of non-Hodgkin ...
Xpovio
Xpovio is used to treat multiple myeloma (MM) or relapsed/refractory diffuse large B-cell lymphoma ...
Zynlonta
Zynlonta (loncastuximab tesirine) is used to treat relapsed or refractory diffuse large B-cell ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.